Growth Metrics

Protalix BioTherapeutics (PLX) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn -1.48%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.48%
Dec 31, 2025 11.93%
Sep 30, 2025 -3.55%
Jun 30, 2025 -57.21%
Mar 31, 2025 -44.95%
Dec 31, 2024 -52.16%
Sep 30, 2024 -13.89%
Jun 30, 2024 302.42%
Mar 31, 2024 79.67%
Dec 31, 2023 153.62%
Sep 30, 2023 1,900.00%
Jun 30, 2023 41.71%
Mar 31, 2023 -34.69%
Dec 31, 2022 28.95%
Sep 30, 2022 -89.53%
Jun 30, 2022 -53.33%
Mar 31, 2022 2.45%
Dec 31, 2021 -58.78%
Sep 30, 2021 -59.62%
Jun 30, 2021 37.87%
Mar 31, 2021 89.33%
Dec 31, 2020 329.66%
Sep 30, 2020 890.70%
Jun 30, 2020 97.10%
Mar 31, 2020 48.62%
Dec 31, 2019 -43.54%
Sep 30, 2019 714.29%
Jun 30, 2019 885.71%
Mar 31, 2019 367.74%
Dec 31, 2018 808.70%
Sep 30, 2018 -118.67%
Jun 30, 2018 -85.71%
Mar 31, 2018 -47.46%
Dec 31, 2017 -79.37%
Sep 30, 2017 -53.99%
Jun 30, 2017 -56.83%
Mar 31, 2017 -68.53%
Dec 31, 2016 -41.78%
Sep 30, 2016 -63.45%
Jun 30, 2016 -59.03%
Mar 31, 2016 -10.50%
Mar 31, 2015 -37.46%
Mar 31, 2014 -50.99%
Dec 31, 2013 -62.28%
Sep 30, 2013 -75.54%
Jun 30, 2013 -70.97%
Mar 31, 2013 959.69%
Dec 31, 2012 980.77%
Sep 30, 2012 4,139.13%
Jun 30, 2012 2,970.87%
Mar 31, 2012 -46.69%
Dec 31, 2011 -60.51%
Sep 30, 2011 -35.21%
Jun 30, 2011 -15.89%